Chemoinformaics analysis of DELPHINIDIN-3,5-DIGLUCOSIDE
| Molecular Weight | 626.52 | nRot | 7 |
| Heavy Atom Molecular Weight | 596.28 | nRig | 30 |
| Exact Molecular Weight | 626.148 | nRing | 5 |
| Solubility: LogS | -2.209 | nHRing | 3 |
| Solubility: LogP | -1.676 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 1 |
| nHetero | 17 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 17 | No. of Arom Bond | 16 |
| nHA | 17 | APOL | 78.7278 |
| nHD | 11 | BPOL | 39.6442 |
| QED | 0.116 |
| Synth | 5.004 |
| Natural Product Likeliness | 1.336 |
| NR-PPAR-gamma | 0.878 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.985 |
| HIA | 0.97 |
| CACO-2 | -6.469 |
| MDCK | 0.000116263 |
| BBB | 0.4 |
| PPB | 0.738795 |
| VDSS | 0.554 |
| FU | 0.246202 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.01 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.047 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.062 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.126 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.002 |
| CL | 1.428 |
| T12 | 0.621 |
| hERG | 0.021 |
| Ames | 0.569 |
| ROA | 0.038 |
| SkinSen | 0.017 |
| Carcinogencity | 0.042 |
| EI | 0.004 |
| Respiratory | 0.01 |
| NR-Aromatase | 0.721 |
| Antiviral | Yes |
| Prediction | 0.807622 |